This website uses cookies

The University of Liège wishes to use cookies or trackers to store and access your personal data, to perform audience measurement. Some cookies are necessary for the website to function. Cookie policy.

Profil

LA MARCA Marilèna

Département de gestion des systèmes d'informations (GSI) > Secteur codage et nomenclature

See author's contact details
Main Referenced Co-authors
Demols, A. (1)
Gay, F. (1)
Hendlisz, A. (1)
Marechal, R. (1)
Monsaert, E. (1)
Main Referenced Keywords
advanced and metastatic pancreatic cancer (1); gemcitabine plus oxaliplatin (1); second line chemotherapy (1);
Main Referenced Disciplines
Oncology (1)

Publications (total 1)

The most downloaded
30 downloads
Demols, A., La Marca, M., Polus, M., Marechal, R., Gay, F., Monsaert, E., Hendlisz, A., & Van Laethem, J. L. (27 February 2006). Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study. British Journal of Cancer, 94 (4), 481-485. doi:10.1038/sj.bjc.6602966 https://hdl.handle.net/2268/257224

The most cited

134 citations (OpenAlex)

Demols, A., La Marca, M., Polus, M., Marechal, R., Gay, F., Monsaert, E., Hendlisz, A., & Van Laethem, J. L. (27 February 2006). Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study. British Journal of Cancer, 94 (4), 481-485. doi:10.1038/sj.bjc.6602966 https://hdl.handle.net/2268/257224

Demols, A., La Marca, M., Polus, M., Marechal, R., Gay, F., Monsaert, E., Hendlisz, A., & Van Laethem, J. L. (27 February 2006). Gemcitabine and oxaliplatin (GEMOX) in gemcitabine refractory advanced pancreatic adenocarcinoma: a phase II study. British Journal of Cancer, 94 (4), 481-485. doi:10.1038/sj.bjc.6602966
Peer Reviewed verified by ORBi

Contact ORBi